WebMD Health Corp. Sets New 1-Year High at $42.78 (WBMD)
WebMD Health Corp. (NASDAQ:WBMD) set a new 52-week high on Tuesday, American Banking News.com reports. The company traded as high as $42.78 and last traded at $42.37, with a volume of 887,447 shares. The stock had previously closed at $39.78.
WBMD has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of WebMD Health Corp. from an “outperform” rating to a “neutral” rating in a research note to investors on Monday, December 23rd. They now have a $44.30 price target on the stock. Separately, analysts at Goldman Sachs Group Inc. upgraded shares of WebMD Health Corp. from a “sell” rating to a “neutral” rating in a research note to investors on Monday, December 2nd. Finally, analysts at Stifel Nicolaus raised their price target on shares of WebMD Health Corp. from $40.00 to $43.00 in a research note to investors on Friday, November 8th. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $40.83.
WebMD Health Corp. (NASDAQ:WBMD) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. The company had revenue of $130.90 million for the quarter, compared to the consensus estimate of $129.74 million. During the same quarter last year, the company posted ($0.02) earnings per share. WebMD Health Corp.’s revenue was up 11.4% compared to the same quarter last year.
WebMD Health Corp. is a provider of health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.